Celso A Reis Selected Research

Polysaccharides (Glycans)

2/2022	Glycans as Targets for Drug Delivery in Cancer.
1/2022	CAR-Ts: new perspectives in cancer therapy.
1/2021	Mycobacterium tuberculosis Infection Up-Regulates Sialyl Lewis X Expression in the Lung Epithelium.
1/2021	Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management.
1/2021	Emerging glyco-based strategies to steer immune responses.
1/2021	Adhesion of Helicobacter Species to the Human Gastric Mucosa: A Deep Look Into Glycans Role.
1/2021	Aberrant protein glycosylation in cancer: implications in targeted therapy.
1/2021	Glycosylation of Cancer Extracellular Vesicles: Capture Strategies, Functional Roles and Potential Clinical Applications.
1/2021	Glycosylation is a key in SARS-CoV-2 infection.
1/2020	Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Celso A Reis Research Topics

Disease

82	Neoplasms (Cancer) 02/2022 - 06/2003
29	Carcinoma (Carcinomatosis) 12/2020 - 03/2002
26	Stomach Neoplasms (Stomach Cancer) 03/2021 - 09/2003
16	Infections 01/2022 - 01/2004
16	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2007
8	Metaplasia 01/2011 - 03/2002
7	Carcinogenesis 11/2016 - 08/2009
7	Breast Neoplasms (Breast Cancer) 08/2015 - 09/2003
6	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 08/2011
4	Hypoxia (Hypoxemia) 01/2018 - 01/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 06/2013
3	Inflammation (Inflammations) 01/2021 - 09/2015
3	Polyps 12/2020 - 06/2009
3	Adenocarcinoma 06/2018 - 01/2011
3	Persistent Infection 11/2016 - 09/2015
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2015 - 03/2002
3	Gastritis 03/2013 - 12/2005
2	Microsatellite Instability 01/2021 - 09/2018
2	Tuberculosis (Tuberculoses) 01/2021 - 01/2020
2	Pathologic Processes 10/2018 - 11/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2018 - 01/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2021
1	Communicable Diseases (Infectious Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

49	Polysaccharides (Glycans)IBA 02/2022 - 02/2006
27	AntigensIBA 01/2022 - 06/2003
19	Biomarkers (Surrogate Marker)IBA 08/2021 - 04/2010
17	Glycoproteins (Glycoprotein)IBA 02/2022 - 09/2003
17	MucinsIBA 06/2018 - 03/2002
15	Sialyl Lewis X AntigenIBA 01/2021 - 11/2004
13	Proteins (Proteins, Gene)FDA Link 08/2021 - 12/2005
12	Cadherins (E-Cadherin)IBA 10/2016 - 07/2007
11	EnzymesIBA 01/2021 - 10/2006
11	Biological ProductsIBA 01/2021 - 03/2002
10	CarbohydratesIBA 06/2013 - 03/2002
9	Monoclonal AntibodiesIBA 02/2022 - 03/2002
9	EpitopesIBA 01/2021 - 06/2003
8	GlycosyltransferasesIBA 01/2020 - 06/2003
6	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2021 - 11/2004
6	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 08/2011
6	SialyltransferasesIBA 01/2020 - 01/2013
4	Pharmaceutical PreparationsIBA 02/2022 - 09/2015
4	Carrier Proteins (Binding Protein)IBA 02/2022 - 01/2019
4	GlycoconjugatesIBA 01/2022 - 01/2013
4	Hyaluronic Acid (Hyaluronan)IBA 02/2021 - 10/2018
4	Peptides (Polypeptides)IBA 01/2021 - 06/2003
4	sialosyl-Tn antigenIBA 01/2011 - 10/2004
3	VaccinesIBA 02/2022 - 10/2003
3	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2022 - 02/2006
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 06/2016
3	Protein Isoforms (Isoforms)IBA 01/2020 - 04/2013
3	Mucin-1 (CA 15-3 Antigen)IBA 10/2018 - 02/2006
3	LectinsIBA 01/2018 - 01/2012
3	Lewis Blood Group AntigensIBA 01/2017 - 10/2006
3	IntegrinsIBA 08/2016 - 11/2013
3	AntibodiesIBA 07/2012 - 10/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2013
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
2	LigandsIBA 08/2021 - 11/2004
2	ErbB Receptors (EGF Receptor)IBA 08/2021 - 10/2017
2	Proteoglycans (Proteoglycan)IBA 03/2021 - 01/2016
2	Thomsen-Friedenreich antigenIBA 01/2021 - 09/2018
2	Blood Group Antigens (Blood Groups)IBA 01/2021 - 01/2010
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021 - 04/2013
2	GlycosaminoglycansIBA 01/2021 - 01/2021
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 07/2007
2	Neuraminidase (Sialidase)IBA 01/2021 - 01/2015
2	TransferasesIBA 01/2020 - 06/2003
2	ChitosanIBA 01/2020 - 12/2013
2	beta-Galactoside alpha-2,3-SialyltransferaseIBA 01/2019 - 01/2014
2	Phenobarbital (Luminal)FDA Link 12/2017 - 09/2014
2	Galectin 3 (LGALS3)IBA 12/2016 - 01/2015
2	AcetylglucosamineIBA 02/2016 - 05/2006
2	GlycopeptidesIBA 08/2011 - 02/2006
2	Gastric MucinsIBA 03/2006 - 03/2002
2	Cancer VaccinesIBA 02/2006 - 02/2006
2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 05/2005 - 10/2003
2	SaponinsIBA 05/2005 - 10/2003
1	Immunoconjugates (Immunoconjugate)IBA 02/2022
1	phenethyl isothiocyanate (PEITC)IBA 01/2022
1	Artificial ReceptorsIBA 01/2022
1	P-SelectinIBA 08/2021
1	BiglycanIBA 03/2021
1	Small Leucine-Rich ProteoglycansIBA 03/2021
1	AlginatesIBA 01/2021
1	HydrogelsIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	CytokinesIBA 01/2021

Therapy/Procedure

19	Therapeutics 02/2022 - 01/2012
6	Precision Medicine 01/2020 - 01/2016
4	Ligation 08/2016 - 02/2010
2	Microspheres (Microsphere) 01/2020 - 12/2013